Most life sciences organizations have a defined market access strategy, devising plans and aligning teams to drive remarkable results across time-to-market, formulary access, patient access, and more. What increasingly defines success, however, is how effectively these strategies are operationalized through connected systems and workflows within the execution ecosystem. When this alignment is not fully realized, pricing decisions are made with limited payer insights, contracting teams operate on outdated data, and evidence arrives too late to influence outcomes.
As a specialized Market Access modernization partner, we worked with Everest Group to analyze this landscape and develop practical frameworks that strengthen the market access program execution.
This whitepaper, curated by Everest Group’s life sciences domain experts, outlines how to close this gap through a next-generation market access blueprint that connects pricing, contracting, evidence generation, and data within a unified, execution-focused model.
Additionally, SRM Tech demonstrates how this blueprint can be effectively put into practice through our Market Access CoE, combining deep domain expertise, platform capabilities, and AI-driven accelerators such as BIOeRA.
Download the whitepaper to explore practical frameworks and workflows to reduce revenue leakage, strengthen compliance, and accelerate patient access through a more connected and execution-driven market access model.
